A recent meta-analysis of 1241 glioblastoma patients confirmed our results by showing that high CHI3L1 expression was associated with poor prognosis (HR  =  1.46; 95% CI, 1.33–1.61; p  <  0.001) [31]. Here, CHI3L1 is linked to glioblastoma.